Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The aim of our study is to evaluate the efficacy of rapamycin with Refractory Immune
Thrombocytopenic Purpura (RITP) and explore the further mechanism.
Details
Lead Sponsor:
First Affiliated Hospital of Suzhou Medical College